HTFL vs BFLY vs VREX Stock Comparison

Heartflow, Butterfly Network and Varex Imaging Prices as of Oct 26, 2026 Peers: Industry group
HTFL Heartflow, Inc.
$57.01 +15.9% 1M +50.5% 1Y
Market cap
$5.00B
P/E
–
Revenue (TTM)
$202.91M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
BFLY Butterfly Network, Inc.
$6.65 -29.2% 1M +198.2% 1Y
Market cap
$1.93B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
VREX Varex Imaging Corp
$18.41 -0.2% 1M +53.5% 1Y
Market cap
$776.53M
P/E
35.1x
Revenue (TTM)
$865.00M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins

Head to Head

7 decided of 12

Heartflow leads on 3 of the 12 questions below (Heartflow 3, Varex Imaging 3, Butterfly Network 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHTFLBFLYVREXLeader
Larger companyMarket capitalisation $5.00B $1.93B $776.53M HTFL
Cheaper on earningsLower P/E, profitable companies only -49.9x -25.8x 35.1x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 21.2x –
Faster revenue growthRevenue growth, trailing twelve months +42.5% +28.1% +5.3% HTFL
More profitableNet margin, trailing twelve months -49.4% -66.7% 2.6% VREX
Better return on capitalReturn on invested capital — — 6.9% –
Less leveragedLower net debt / EBITDA — — 2.5x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +50.5% +198.2% +53.5% BFLY
Better 5-year returnAnnualised price return, 5 years — -8.0%/yr -7.0%/yr VREX
Less volatileAnnualised volatility, 1 year 76.9% 114.6% 57.6% VREX
Higher overall scoreMean of the five percentile scores vs peers 57/100 44/100 51/100 HTFL

Percentile Scorecard

HTFLBFLYVREX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHTFLBFLYVREX
Valuation 8 #209 of 228 29 #163 of 228 87 #31 of 228
Growth 78 #50 of 221 68 #72 of 221 23 #170 of 221
Profitability 49 #107 of 208 31 #143 of 208 66 #71 of 208
Financial Health 91 #22 of 239 60 #96 of 239 41 #141 of 239
Shareholder Returns – 35 #90 of 137 36 #88 of 137
Overall 57 44 51
  • HTFL ranked among 248 companies in Medical Devices and Diagnostics
  • BFLY ranked among 248 companies in Medical Devices and Diagnostics
  • VREX ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHTFLBFLYVREXSPY
1 month +15.9%-29.2%-0.2% -0.8%
3 months +124.7%-6.2%+67.7% +3.5%
6 months +79.7%+21.4%+44.8% +7.0%
Year to date +95.6%+75.0%+58.0% +12.2%
1 year +50.5%+198.2%+53.5% +13.0%
3 years —+741.8%+6.4% +86.3%
3 years, per year —+103.5%+2.1% +23.1%
5 years —-34.2%-30.3% +68.6%
5 years, per year —-8.0%-7.0% +11.0%

Risk

MeasureHTFLBFLYVREXSPY
Volatility, 1Y 76.9%114.6%57.6% 12.7%
Downside volatility, 1Y 77.5%91.7%50.0% 12.7%
Beta vs S&P 500, 1Y 1.902.971.11 1.00
Return / volatility, 1Y 0.661.730.93 1.02
Max drawdown, 5Y -48.7%-93.4%-78.8% -25.4%
From 52-week high 0.0%-33.1%-0.9% -1.8%
52-week high $57.01$9.94$18.58 $779.14
52-week low $20.49$1.97$9.32 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHTFLBFLYVREX
P/E now vs peer median -49.2xmedian 30.6x -23.3xmedian 30.6x 35.1xmedian 30.6x
P/S now vs peer median 24.4xmedian 3.0x 14.1xmedian 3.0x 0.9xmedian 3.0x
EV/EBITDA now vs peer median —median 17.5x -20.2xmedian 17.5x 10.1xmedian 17.5x
P/FCF now vs peer median —median 23.3x -56.4xmedian 23.3x -38.4xmedian 23.3x
P/B now vs peer median 17.7xmedian 2.4x 8.4xmedian 2.4x 1.5xmedian 2.4x
PEG now vs peer median —median 0.87 -0.86median 0.87 -9.15median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHTFLBFLYVREX
Revenue $202.91M $112.15M $865.00M
Gross profit $160.45M $59.04M $296.90M
Operating income -$64.46M -$79.38M $72.20M
Net income -$100.19M -$74.85M $22.40M
Free cash flow – -$28.04M -$20.20M
R&D $77.26M $38.10M $91.40M
EPS (diluted) $-1.16 $-0.29 $0.52
Cash & equivalents $34.36M $124.66M $99.20M
Total debt – – $347.10M
Shares (diluted) 86.40M 262.10M 42.60M
Enterprise value $4.75B $1.38B $308.33M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHTFLBFLYVREX
P/E -49.2x -23.3x 35.1x
P/FCF – -56.4x -38.4x
P/Operating cash flow – -65.9x 68.7x
P/S 24.4x 14.1x 0.9x
P/B 17.7x 8.4x 1.5x
P/Tangible book 17.7x 8.7x 1.6x
EV/EBITDA – -20.2x 10.1x
EV/EBIT -72.9x -18.4x 14.2x
EV/Revenue 23.1x 13.0x 1.2x
EV/FCF – -52.0x -50.7x
EV/Operating cash flow – -60.7x 90.6x
PEG (3Y EPS CAGR) – -0.86 -9.15

Growth

14 metrics
MetricHTFLBFLYVREX
Revenue growth (1Y) 42.5% 28.1% 5.3%
Revenue CAGR (3Y) – 15.6% -1.2%
Gross profit growth (1Y) 48.8% 8.8% 6.1%
Gross profit CAGR (3Y) – 13.3% 1.2%
Operating income growth (1Y) -9.5% -14.8% 297.8%
Operating income CAGR (3Y) – 21.1% -2.3%
Net income growth (1Y) -18.3% -19.1% 116.7%
Net income CAGR (3Y) – 20.8% -9.2%
EPS growth (1Y) 91.4% -12.9% 116.1%
EPS CAGR (3Y) – 27.0% -3.8%
Operating cash flow growth (1Y) – 19.6% -81.1%
Operating cash flow CAGR (3Y) – 44.5% -47.6%
Free cash flow growth (1Y) – 12.2% -155.5%
Free cash flow CAGR (3Y) – 42.8% -33.5%

Profitability

14 metrics
MetricHTFLBFLYVREX
Gross margin 79.1% 52.6% 34.3%
EBITDA margin – -64.4% 11.7%
Operating margin -31.8% -70.8% 8.3%
Pretax margin -49.4% -66.7% 3.2%
Net margin -49.4% -66.7% 2.6%
FCF margin – -25.0% -2.3%
Operating cash flow margin – -21.4% 1.3%
Return on equity -34.5% -39.3% 4.5%
Return on assets -28.5% -26.3% 2.1%
Return on invested capital – – 6.9%
Return on capital employed -20.9% -35.1% 8.0%
Asset turnover 0.6x 0.4x 0.8x
Cash conversion (OCF / net income) – 0.3x 0.5x
Stock comp / revenue 9.6% 21.3% 1.7%

Financial Health

11 metrics
MetricHTFLBFLYVREX
Debt / assets – – 31.6%
Debt / equity – – 0.7x
Net debt / EBITDA – – 2.5x
Debt / FCF – – -17.2x
Liabilities / assets 18.8% 33.1% 53.6%
Equity / assets 81.2% 66.9% 46.4%
Interest coverage – -59.4x 1.9x
Current ratio 5.1x 4.1x 3.4x
Quick ratio 6.6x 2.7x 1.3x
Cash ratio 5.6x 2.1x 0.5x
Altman Z-score 41.82 5.90 2.28

Shareholder Returns

7 metrics
MetricHTFLBFLYVREX
Dividend yield – – –
Net buyback yield – -0.5% -0.4%
Shareholder yield – -0.5% -0.4%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHTFLBFLYVREX
Forward P/E – – 21.2xFY2026
EPS, next fiscal year $-0.43FY2026 $-0.10FY2026 $0.87FY2026
EPS growth, next FY – – -3.3%FY2026
EPS growth, the year after – – +14.9%
Revenue, next fiscal year $261.38MFY2026 $114.50MFY2026 $829.68MFY2026
Revenue growth, next FY +48.5%FY2026 +17.3%FY2026 -1.8%FY2026
Revenue growth, the year after +20.6% +26.0% +2.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHTFLBFLYVREX
Held by institutions 100.0% 59.9% 95.2%
Institutions holding 192 245 186
Change in shares held, QoQ +133.0% +13.9% -2.7%
Institutions buying 140 143 98
Institutions selling 38 59 58
Buyers to sellers 3.68 2.42 1.69

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HTFLBFLYVREX
HTFL 1.00 0.26 0.18
BFLY 0.26 1.00 0.19
VREX 0.18 0.19 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HTFL, BFLY and VREX?

Heartflow (HTFL) is the largest by market capitalisation: Heartflow (HTFL) $5.00B, Butterfly Network (BFLY) $1.93B, Varex Imaging (VREX) $776.53M.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: Heartflow (HTFL) +42.5%, Butterfly Network (BFLY) +28.1%, Varex Imaging (VREX) +5.3%.

Which company is more profitable?

Varex Imaging (VREX) has the highest net margin (Heartflow (HTFL) -49.4%, Butterfly Network (BFLY) -66.7%, Varex Imaging (VREX) 2.6%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Heartflow (HTFL) +50.5%, Butterfly Network (BFLY) +198.2%, Varex Imaging (VREX) +53.5%. Over five years, Varex Imaging (VREX) compounded fastest (Butterfly Network (BFLY) -8.0%/yr, Varex Imaging (VREX) -7.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Varex Imaging (VREX) has been the steadiest (Heartflow (HTFL) 76.9%, Butterfly Network (BFLY) 114.6%, Varex Imaging (VREX) 57.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HTFL, BFLY and VREX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Heartflow (HTFL) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.